Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT06203236

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06203236
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06203236. Randomized; double masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2025-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
Condition
Acute Heart Failure
Condition
Chronic Kidney Diseases
Intervention (Drug)
Furosemide 20 MG
Intervention (Other)
diuretic therapy
Lead sponsor
Assiut University (class: other)

Record details

Record id
cardio:ct-nct06203236
Content hash
de797974892f664dcfea4d0a260e72dc3b6924b763dbe7c92a82a2f2a52d3a7b